|
21 Jul 2007 |
Yondelis (R) receives positive opinion in europe for the treatment of soft tissue sarcoma
|
|
21 Jul 2007 |
BioXell to regain rights to TREM platform following strategic decision by Merck & Co., Inc.
|
|
20 Jul 2007 |
Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
|
|
20 Jul 2007 |
Tercica Completes Enrollment of Clinical Trial MS301 Evaluating Treatment with Increlex in Children with Primary IGFD
|
|
20 Jul 2007 |
Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
|
|
18 Jul 2007 |
Ambrilia Completes Korean Licensing Partnership with Shin Poong for its Long-Acting Formulation of Octreotide
|
|
18 Jul 2007 |
CVBT Announces Positive Pre-Clinical Results for Protein-Based Drug Candidate to Treat Osteoporosis
|
|
17 Jul 2007 |
Affymax(R) Announces Phase 3 Development Plan for Hematide(TM)
|
|
17 Jul 2007 |
NPS Pharmaceuticals Announces Sale of Preotact(R) Royalty to Drug Royalty Corporation (DRC)
|
|
14 Jul 2007 |
Biolex Therapeutics Presents Preclinical Results for Clot Buster BLX-155 at the International Society on Thrombosis and Haemostasis Meeting
|
|
13 Jul 2007 |
Lab International announces positive results from its Growth Hormone Releasing Hormone (GHRH) Phase II trial
|
|
13 Jul 2007 |
SemBioSys achieves critical Apo AI milestone
|
|
13 Jul 2007 |
Bayer HealthCare Reports Positive Preclinical Study Results on Longer-Acting Recombinant Factor VIII Molecules
|
|
11 Jul 2007 |
Protox announces positive clinical data from prostate cancer study
|
|
11 Jul 2007 |
Sinobiomed Updates on Clincial Trial Progress for Recombinant Batroxobin (rBAT)
|
|
11 Jul 2007 |
CardioVascular BioTherapeutics Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease
|
|
11 Jul 2007 |
Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
|
|
10 Jul 2007 |
Roche and Alnylam form major alliance on RNAi therapeutics
|
|
10 Jul 2007 |
Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
|
|
06 Jul 2007 |
Phylogica expands pipeline to acute lung distress
|
|
06 Jul 2007 |
EMEA Approves Kamada’s Plans for Phase II / III Clinical Trials of the Aerosolized Form of AAT for the Treatment of Congenital Emphysema
|
|
04 Jul 2007 |
Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
|
|
03 Jul 2007 |
Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
|
|
29 Jun 2007 |
Merck Serono's fertility treatment Pergoveris(TM) approved in European Union
|
|
29 Jun 2007 |
A 4-Week Therapy with Transition Therapeutics' E1-I.N.T.(TM) Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
|
